FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer

BACKGROUND: FOXD3 is aberrantly regulated in several tumors, but its underlying mechanisms in ovarian cancer (OC) remains largely unknown. The present study aimed to explore the role and associated mechanisms of FOXD3 in OC. METHODS: Microarray data from GEO was used to analyze differential CpG site...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Gui-fang, Chen, Chang-ye, Wang, Juan, Yue, Hai-yan, Tian, Yong, Yang, Ping, Li, Yu-kun, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394078/
https://www.ncbi.nlm.nih.gov/pubmed/30858761
http://dx.doi.org/10.1186/s12935-019-0755-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394078/
https://www.ncbi.nlm.nih.gov/pubmed/30858761
http://dx.doi.org/10.1186/s12935-019-0755-8

Ejemplares similares